Effects of B Cell Depletion by CD19-targeted CAR-T Cells in a Murine Model of Systemic Sclerosis

被引：0
|
作者：
Avouac, Jerome [1 ]
Cauvet, Anne [2 ]
Orvain, Cindy [2 ]
Boulch, Morgane [3 ]
Bousso, Philippe [3 ]
Allanore, Yannick [4 ]
机构：
[1] Univ Paris Cite, Hop Cochin, AP HP, Serv Rhumatol, Paris, France
[2] INSERM, U1016, Paris, France
[3] Inst Pasteur, Paris, France
[4] Univ Paris Cite, Paris, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0956
引用
收藏
页码：1882 / 1883
页数：2
相关论文
共 50 条
  • [41] CD19-Targeted CAR T Cells as Novel Cancer Immunotherapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
    Davila, Marco L.
    Brentjens, Renier J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (10) : 802 - 808
  • [42] The nutritional impact of CD19-targeted CAR-T therapy versus BEAM chemotherapy for adult patients with lymphoma
    Ahern, Katie
    Pham, James
    Sanderson, Robin
    De Farias, Madson Correia
    Walsh, Kevin
    JOURNAL OF HUMAN NUTRITION AND DIETETICS, 2023, 36 (05) : 2099 - 2107
  • [43] Treatment of two pediatric patients with refractory systemic lupus erythematosus using CD19-targeted CAR T-cells
    He, Xue
    Hu, Bin
    Zhang, Yingzi
    Liu, Fei
    Li, Qiuyu
    Zheng, Chen
    Shen, Junjie
    Yang, Zhi
    Wang, Jingjing
    Ma, Daqing
    Qian, Cheng
    Lu, Meiping
    Mao, Jianhua
    AUTOIMMUNITY REVIEWS, 2025, 24 (01)
  • [44] Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicity
    De Matteis, Serena
    Dicataldo, Michele
    Casadei, Beatrice
    Storci, Gianluca
    Laprovitera, Noemi
    Arpinati, Mario
    Maffini, Enrico
    Cortelli, Pietro
    Guarino, Maria
    Vaglio, Francesca
    Naddeo, Maria
    Sinigaglia, Barbara
    Zazzeroni, Luca
    Guadagnuolo, Serafina
    Tomassini, Enrica
    Bertuccio, Salvatore Nicola
    Messelodi, Daria
    Ferracin, Manuela
    Bonafe, Massimiliano
    Zinzani, Pier Luigi
    Bonifazi, Francesca
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [45] Autologous CD19-Targeted Chimeric Antigen Receptor (CAR)T-Cells as the Future of Systemic Lupus Erythematosus Treatment
    Kambayana, Gede
    Rini, Sandra Surya
    CURRENT RHEUMATOLOGY REVIEWS, 2023, 19 (03) : 260 - 269
  • [46] Case Report: Dual Inhibition of HDAC and BTK for Diffuse Large B-Cell Lymphoma After Failure to CD19-Targeted CAR-T Therapy
    Zhu, Weiguo
    Tao, Shi
    Miao, Wenchun
    Liu, Hui
    Yuan, Xianggui
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy
    De Matteis, Serena
    Casadei, Beatrice
    Lolli, Ginevra
    Dicataldo, Michele
    Barbato, Francesco
    Dan, Elisa
    Paccagnella, Andrea
    Sinigaglia, Barbara
    Bertuzzi, Clara
    Arcari, Annalisa
    Zazzeroni, Luca
    Bernuzzi, Patrizia
    Laprovitera, Noemi
    Storci, Gianluca
    Bertuccio, Salvatore Nicola
    Ferracin, Manuela
    Bonafe, Massimiliano
    Zinzani, Pier Luigi
    Bonifazi, Francesca
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [48] Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin's Lymphoma
    Ying, Zhitao
    He, Ting
    Wang, Xiaopei
    Zheng, Wen
    Lin, Ningjing
    Tu, Meifeng
    Xie, Yan
    Ping, Lingyan
    Zhang, Chen
    Liu, Weiping
    Deng, Lijuan
    Qi, Feifei
    Ding, Yanping
    Lu, Xin-an
    Song, Yuqin
    Zhu, Jun
    MOLECULAR THERAPY-ONCOLYTICS, 2019, 15 : 60 - 68
  • [49] Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy
    Lihong An
    Yuehui Lin
    Biping Deng
    Zhichao Yin
    Defeng Zhao
    Zhuojun Ling
    Tong Wu
    Yongqiang Zhao
    Alex H. Chang
    Chunrong Tong
    Shuangyou Liu
    BMC Cancer, 22
  • [50] Efficacy and safety of humanized CD19 CAR-T as a salvage therapy for recurrent CNSL of B-ALL following murine CD19 CAR-T cell therapy
    Li, Xin
    Liu, Mei-Jing
    Mou, Nan
    Yang, Zhen-Xing
    Wang, Jia
    Mu, Juan
    Zhu, Hai-Bo
    Deng, Qi
    ONCOLOGY LETTERS, 2021, 22 (05)
12345